Global Medical REIT Inc Aktie News

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that the Company will change its name, effective as of 12:01 a.m., Eastern Time, on February 23, 2026, to “Chiron Real Estate Inc.” Beginning on February 23, 2026, the Company's common stock will trade on the New York Stock Exchange (the “NYSE”) under the new name, “Chiron Real Estate...

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that information regarding the federal income tax treatment of the dividends paid in 2025 on the Company's Common Stock and Series A Preferred Stock has been posted to the Company's website, at the following link. https://investors.globalmedicalreit.com/stock-data/dividend-tax-inform...

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Henry Cole has notified the Board of Directors (the “Board”) that he plans to step down as a member of the Board at the end of his current term. Henry Cole's Stepping Down from Board of Directors Mr. Cole has served on the Board as an Independent Director since the Company's ince...

Global Medical REIT offers a diversified, granular healthcare property portfolio with 95.2% occupancy and an average remaining lease term of 5.3 years. GMRE has proactively extended and staggered its debt maturities, raised $50M in Series B preferred equity, and improved balance sheet flexibility. The Series A Preferred Shares yield 7.7%, are past call, and are unlikely to be redeemed soon give...

Global Medical REIT offers a compelling value proposition, with an 8.9% dividend yield and a forward P/FFO of 8.3. GMRE's diversified healthcare portfolio, 95%+ occupancy, and 2.1% annual rent escalators support steady cash flows and modest growth. Management's proactive debt restructuring extends maturities, mitigating refinancing risk.

Active investors have an advantage in the REIT sector. Individual REITs often get mispriced, resulting in opportunities to earn alpha-rich returns. We highlight a clear example of that.

Armada Hoffler, Easterly Government Properties, and Global Medical REIT trade at deep NAV discounts and low FFO multiples after dividend cuts. AHH, DEA, and GMRE offer 8.5%–9% yields and 60%–125% potential capital appreciation if multiples revert to REIT averages. Tax-loss selling and AI-driven market rotation have intensified REIT discounts, creating unusually attractive entry points for value...

Global Medical REIT is rated a buy, driven by strong AFFO growth, robust dividend coverage, and sector tailwinds. GMRE redeploys capital into higher cap-rate assets, maintains low tenant concentration risk, and benefits from geographic diversification including presence in high-growth regions like Texas and Florida. Despite elevated leverage (D/E 1.50), GMRE's forward P/FFO of 8.6 is 35% below ...